Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYR0201 granules for pediatric acute upper respiratory tract infection (wind-heat common cold pattern)
CTR20233612Phase 2Completed
- Sponsor
- Tiandi Hengyi Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HYR0201 in upper respiratory infection (URI), sponsored by Tiandi Hengyi Pharmaceutical. Started Nov 2023; status: completed.
02
Drugs
HYR0201
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20233612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233612.